SCHEMBL26765093

SCHEMBL26765093

Cc1ccccc1C(=O)N1CCC(CCCCNC(=O)NCc2ccccc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ HTR2B P41595 1/20 0.60
▸ MAPK14 Q16539 1/20 0.60
▸ KEAP1 Q14145 3/20 0.50
▸ NFE2L2 Q16236 3/20 0.50
▸ NAMPT P43490 3/20 0.50
▸ HDAC3 O15379 1/20 0.49
▸ HDAC4 P56524 1/20 0.49
▸ HDAC1 Q13547 1/20 0.49
▸ HDAC7 Q8WUI4 1/20 0.49
▸ HDAC2 Q92769 1/20 0.49
▸ HDAC10 Q969S8 1/20 0.49
▸ HDAC11 Q96DB2 1/20 0.49
▸ HDAC8 Q9BY41 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ HDAC9 Q9UKV0 1/20 0.49
▸ HDAC5 Q9UQL6 1/20 0.49
▸ CCR3 P51677 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011155 0.92 CYP2C9 (0.51) CYP2C9CYP2C19HTR2BMAPK14KEAP1
SCHEMBL24011095 0.92 NAMPT (0.51) CYP2C9CYP2C19HTR2BMAPK14KEAP1
SCHEMBL24011100 0.91 CYP2C9 (0.49) CYP2C9CYP2C19HTR2BMAPK14KEAP1
SCHEMBL24011099 0.91 CYP2C9 (0.49) CYP2C9CYP2C19HTR2BMAPK14KEAP1
SCHEMBL26765090 0.90 NAMPT (0.50) CYP2C9CYP2C19HTR2BMAPK14KEAP1
SCHEMBL24011347 0.84 CYP2C9 (0.51) CYP2C9CYP2C19HTR2BMAPK14NAMPT
SCHEMBL24011315 0.84 NAMPT (0.47) CYP2C9CYP2C19HTR2BMAPK14NAMPT
SCHEMBL24011238 0.84 ALDH1A1 (0.57) CYP2C9CYP2C19HTR2BMAPK14NAMPT
SCHEMBL24011317 0.81 CCR5 (0.54) KEAP1NFE2L2NAMPTCHRM2MEN1
SCHEMBL24011185 0.80 NAMPT (0.61) CYP2C9HTR2BKEAP1NFE2L2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT CYP2C9 1551/4885CYP2C19 1361/4885HTR2B 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback